COM:PARATEKPHARMA
Paratek Pharma
- Stock
Last Close
2.19
20/09 20:00
Market Cap
127.83M
Beta: -
Volume Today
4.48M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
net income | -27.45M - | -17.84M 35.02% | -70.86M 297.31% | -111.64M 57.54% | -89.07M 20.21% | -112.36M 26.14% | -128.79M 14.63% | -96.54M 25.04% | -59.08M 38.80% | -63.57M 7.59% | |
depreciation and amortization | 90K - | 196K 117.78% | 714K 264.29% | 2.30M 222.55% | 1.27M 44.94% | -1.07M 184.15% | -1.29M 21.09% | 578K 144.74% | 391K 32.35% | 490K 25.32% | |
deferred income tax | 9.14M - | 2.86M 68.71% | 743K - | 107K 85.60% | 1.06M - | ||||||
stock based compensation | 3.33M - | 706K 78.83% | 5.06M 617.00% | 10.79M 113.20% | 16.90M 56.62% | 25.49M 50.83% | 14.29M 43.93% | 10.25M 28.31% | 14.34M 39.89% | 12.32M 14.07% | |
change in working capital | 5.37M - | -11.51M 314.12% | 10.54M 191.57% | 4.55M 56.85% | -8.24M 281.22% | 3.92M 147.61% | -21.50M 648.02% | -20.29M 5.64% | -8.19M 59.63% | -20.79M 153.89% | |
accounts receivables | -4.76M - | -2.71M 43.22% | 4.96M 283.36% | -4.83M 197.44% | 4.44M 191.87% | -11.23M 352.88% | -7.46M 33.57% | -21.79M 192.06% | -40.42M 85.56% | ||
inventory | -715K - | -10.86M 1,418.32% | -11.76M 8.33% | -15.50M 31.84% | -9.09M 41.36% | ||||||
accounts payables | -588K - | -641K - | -623K 2.81% | 1.57M 352.17% | 6.77M 330.81% | 7.68M 13.45% | |||||
other working capital | 5.96M - | -6.74M 213.10% | 13.24M 296.38% | -413K 103.12% | -3.41M 724.94% | 839K 124.63% | 1.21M 43.98% | -2.64M 318.38% | 22.33M 946.55% | 21.05M 5.75% | |
other non cash items | 3.83M - | 9.91M 158.67% | -135K 101.36% | -104K 22.96% | 565K 643.27% | 2.72M 381.59% | 3.24M 19.11% | 1.52M 53.16% | 4.27M 181.49% | 5.41M 26.54% | |
net cash provided by operating activities | -14.82M - | -18.53M 25.08% | -54.68M 195.05% | -94.10M 72.08% | -78.57M 16.50% | -81.18M 3.32% | -134.04M 65.12% | -103.42M 22.84% | -48.27M 53.33% | -66.14M 37.01% | |
investments in property plant and equipment | -856K - | -690K 19.39% | -1.12M 61.88% | -60K 94.63% | -239K 298.33% | -376K 57.32% | -373K 0.80% | -36K 90.35% | |||
acquisitions net | 13.69M - | -715K - | -239K 66.57% | ||||||||
purchases of investments | -69.81M - | -135.80M - | -180.29M 32.76% | -292.86M 62.44% | -102.21M 65.10% | -29.63M 71.01% | -15.12M 48.97% | -15.16M 0.28% | |||
sales maturities of investments | 54.73M - | 60.11M - | 138.75M 130.84% | 165.05M 18.96% | 237M 43.59% | 122.50M 48.31% | 20M 83.67% | 30M 50% | |||
other investing activites | 20K - | -21K 205.00% | 253K 1,304.76% | 1.63M 542.69% | 655K 59.72% | 715K 9.16% | 239K 66.57% | ||||
net cash used for investing activites | -15.06M - | 13.67M 190.74% | -603K 104.41% | -74.76M 12,297.51% | -42.00M 43.82% | -127.87M 204.45% | 134.55M 205.22% | 92.50M 31.26% | 4.51M 95.12% | 14.80M 228.25% | |
debt repayment | -70M - | -319K 99.54% | -2.89M 805.33% | ||||||||
common stock issued | 445K - | 89.76M 20,071.01% | 71.28M 20.59% | 70.93M 0.49% | 82.80M 16.73% | 51.52M 37.78% | 26.56M 48.45% | 21.89M 17.58% | 18.39M 15.98% | 7.33M 60.15% | |
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 9.75M - | 19.45M 99.53% | 19.59M 0.68% | 20.23M 3.32% | 169.21M 736.22% | 31.06M 81.64% | 59.45M 91.38% | 259K 99.56% | 652K 151.74% | ||
net cash used provided by financing activities | 445K - | 99.51M 22,261.80% | 90.73M 8.82% | 90.52M 0.24% | 103.03M 13.83% | 220.73M 114.24% | 57.62M 73.89% | 11.34M 80.32% | 18.33M 61.66% | 5.09M 72.22% | |
effect of forex changes on cash | |||||||||||
net change in cash | -29.43M - | 94.64M 421.56% | 35.45M 62.55% | -78.34M 321.01% | -17.55M 77.60% | 11.67M 166.53% | 58.13M 397.95% | 415K 99.29% | -25.43M 6,227.95% | -46.24M 81.84% | |
cash at beginning of period | 39.37M - | 1.21M 96.92% | 95.86M 7,808.91% | 131.30M 36.98% | 52.96M 59.66% | 35.83M 32.35% | 47.50M 32.58% | 105.63M 122.38% | 106.05M 0.39% | 80.62M 23.98% | |
cash at end of period | 9.94M - | 95.86M 864.83% | 131.30M 36.98% | 52.96M 59.66% | 35.42M 33.13% | 47.50M 34.13% | 105.63M 122.38% | 106.05M 0.39% | 80.62M 23.98% | 34.37M 57.36% | |
operating cash flow | -14.82M - | -18.53M 25.08% | -54.68M 195.05% | -94.10M 72.08% | -78.57M 16.50% | -81.18M 3.32% | -134.04M 65.12% | -103.42M 22.84% | -48.27M 53.33% | -66.14M 37.01% | |
capital expenditure | -856K - | -690K 19.39% | -1.12M 61.88% | -60K 94.63% | -239K 298.33% | -376K 57.32% | -373K 0.80% | -36K 90.35% | |||
free cash flow | -14.82M - | -18.53M 25.08% | -55.54M 199.67% | -94.79M 70.67% | -79.69M 15.93% | -81.24M 1.94% | -134.28M 65.29% | -103.80M 22.70% | -48.65M 53.13% | -66.18M 36.04% |
All numbers in (except ratios and percentages)